Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Cannabinoid Receptors: Where They are and What They do

Cannabinoid Receptors: Where They are and What They do The endocannabinoid system consists of the endogenous cannabinoids (endocannabinoids), cannabinoid receptors and the enzymes that synthesise and degrade endocannabinoids. Many of the effects of cannabinoids and endocannabinoids are mediated by two G protein‐coupled receptors (GPCRs), CB1 and CB2, although additional receptors may be involved. CB1 receptors are present in very high levels in several brain regions and in lower amounts in a more widespread fashion. These receptors mediate many of the psychoactive effects of cannabinoids. CB2 receptors have a more restricted distribution, being found in a number of immune cells and in a few neurones. Both CB1 and CB2 couple primarily to inhibitory G proteins and are subject to the same pharmacological influences as other GPCRs. Thus, partial agonism, functional selectivity and inverse agonism all play important roles in determining the cellular response to specific cannabinoid receptor ligands. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Neuroendocrinology Wiley

Cannabinoid Receptors: Where They are and What They do

Mackie, K.
Journal of Neuroendocrinology , Volume 20 – May 1, 2008
Download PDF
5 pages

Loading next page...
 
/lp/wiley/cannabinoid-receptors-where-they-are-and-what-they-do-xy0q0lhnXS
Publisher
Wiley
Copyright
© 2008 The Author. Journal Compilation © 2008 Blackwell Publishing Ltd
ISSN
0953-8194
eISSN
1365-2826
DOI
10.1111/j.1365-2826.2008.01671.x
pmid
18426493
Publisher site
See Article on Publisher Site

Abstract

The endocannabinoid system consists of the endogenous cannabinoids (endocannabinoids), cannabinoid receptors and the enzymes that synthesise and degrade endocannabinoids. Many of the effects of cannabinoids and endocannabinoids are mediated by two G protein‐coupled receptors (GPCRs), CB1 and CB2, although additional receptors may be involved. CB1 receptors are present in very high levels in several brain regions and in lower amounts in a more widespread fashion. These receptors mediate many of the psychoactive effects of cannabinoids. CB2 receptors have a more restricted distribution, being found in a number of immune cells and in a few neurones. Both CB1 and CB2 couple primarily to inhibitory G proteins and are subject to the same pharmacological influences as other GPCRs. Thus, partial agonism, functional selectivity and inverse agonism all play important roles in determining the cellular response to specific cannabinoid receptor ligands.

Journal

Journal of Neuroendocrinology – Wiley

Published: May 1, 2008

References

  • Role of endogenous cannabinoids in synaptic signaling
    Freund, Freund; Katona, Katona; Piomelli, Piomelli
  • International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
    Howlett, Howlett; Barth, Barth; Bonner, Bonner; Cabral, Cabral; Casellas, Casellas; Devane, Devane; Felder, Felder; Herkenham, Herkenham; Mackie, Mackie; Martin, Martin; Mechoulam, Mechoulam; Pertwee, Pertwee
  • Cannabinoid receptors as therapeutic targets
    Mackie, Mackie
  • Targeted lipidomics: discovery of new fatty acyl amides
    Tan, Tan; Bradshaw, Bradshaw; Rimmerman, Rimmerman; Srinivasan, Srinivasan; Yu, Yu; Krey, Krey; Mon, Mon; Chen, Chen; Hu, Hu; Pickens, Pickens; Walker, Walker
  • The complications of promiscuity: endocannabinoid action and metabolism
    Alexander, Alexander; Kendall, Kendall
  • Critical enzymes involved in endocannabinoid metabolism
    Basavarajappa, Basavarajappa
  • Biosynthetic pathways of the endocannabinoid anandamide
    Okamoto, Okamoto; Wang, Wang; Morishita, Morishita; Ueda, Ueda
  • Endocannabinoid biosynthesis proceeding through glycerophospho‐N‐acyl ethanolamine and a role for alpha/beta‐hydrolase 4 in this pathway
    Simon, Simon; Cravatt, Cravatt
  • Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study
    Herkenham, Herkenham; Lynn, Lynn; Johnson, Johnson; Melvin, Melvin; De Costa, De Costa; Rice, Rice
  • Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles
    Jansen, Jansen; Haycock, Haycock; Ward, Ward; Seybold, Seybold
  • Structure of a cannabinoid receptor and functional expression of the cloned cDNA
    Matsuda, Matsuda; Lolait, Lolait; Brownstein, Brownstein; Young, Young; Bonner, Bonner
  • Molecular characterization of a peripheral receptor for cannabinoids
    Munro, Munro; Thomas, Thomas; Abu‐Shaar, Abu‐Shaar
  • New perspectives on enigmatic vanilloid receptors
    Szallasi, Szallasi; Di Marzo, Di Marzo
  • Receptor‐independent effects of endocannabinoids on ion channels
    Oz, Oz
  • The orphan receptor GPR55 is a novel cannabinoid receptor
    Ryberg, Ryberg; Larsson, Larsson; Sjogren, Sjogren; Hjorth, Hjorth; Hermansson, Hermansson; Leonova, Leonova; Elebring, Elebring; Nilsson, Nilsson; Drmota, Drmota; Greasley, Greasley
  • Distribution of cannabinoid receptors in the central and peripheral nervous system
    Mackie, Mackie
  • Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain
    Marsicano, Marsicano; Lutz, Lutz
  • Localization of cannabinoid receptor mRNA in rat brain
    Matsuda, Matsuda; Bonner, Bonner; Lolait, Lolait
  • Endocannabinoid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron types
    Bodor, Bodor; Katona, Katona; Nyiri, Nyiri; Mackie, Mackie; Ledent, Ledent; Hajos, Hajos; Freund, Freund
  • CB1 cannabinoid receptors are enriched in the perisynaptic annulus and on preterminal segments of hippocampal GABAergic axons
    Nyiri, Nyiri; Cserep, Cserep; Szabadits, Szabadits; Mackie, Mackie; Freund, Freund
  • Molecular composition of the endocannabinoid system at glutamatergic synapses
    Katona, Katona; Urban, Urban; Wallace, Wallace; Ledent, Ledent; Jung, Jung; Piomelli, Piomelli; Mackie, Mackie; Freund, Freund
  • The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis
    Cota, Cota; Marsicano, Marsicano; Tschop, Tschop; Grubler, Grubler; Flachskamm, Flachskamm; Schubert, Schubert; Auer, Auer; Yassouridis, Yassouridis; Thöne‐Reineke, Thöne‐Reineke; Ortmann, Ortmann; Tomassoni, Tomassoni; Cervino, Cervino; Nisoli, Nisoli; Linthorst, Linthorst; Pasquali, Pasquali; Lutz, Lutz; Stalla, Stalla; Pagotto, Pagotto
  • Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet‐induced obesity
    Osei‐Hyiaman, Osei‐Hyiaman; DePetrillo, DePetrillo; Pacher, Pacher; Liu, Liu; Radaeva, Radaeva; Bátkai, Bátkai; Harvey‐White, Harvey‐White; Mackie, Mackie; Offertáler, Offertáler; Wang, Wang; Kunos, Kunos
  • CB1 receptors: emerging evidence for central and peripheral mechanisms that regulate energy balance, metabolism, and cardiovascular health
    Cota, Cota
  • The expression of receptors for endocannabinoids in human and rodent skeletal muscle
    Cavuoto, Cavuoto; McAinch, McAinch; Hatzinikolas, Hatzinikolas; Janovska, Janovska; Game, Game; Wittert, Wittert
  • Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations
    Galiegue, Galiegue; Mary, Mary; Marchand, Marchand; Dussossoy, Dussossoy; Carriere, Carriere; Carayon, Carayon; Bouaboula, Bouaboula; Shire, Shire; Le Fur, Le Fur; Casellas, Casellas
  • Peripheral cannabinoid receptor, CB2, regulates bone mass
    Ofek, Ofek; Karsak, Karsak; Leclerc, Leclerc; Fogel, Fogel; Frenkel, Frenkel; Wright, Wright; Tam, Tam; Attar‐Namdar, Attar‐Namdar; Kram, Kram; Shohami, Shohami; Mechoulam, Mechoulam; Zimmer, Zimmer; Bab, Bab
  • Identification and functional characterization of brainstem cannabinoid CB2 receptors
    Van Sickle, Van Sickle; Duncan, Duncan; Kingsley, Kingsley; Mouihate, Mouihate; Urbani, Urbani; Mackie, Mackie; Stella, Stella; Makriyannis, Makriyannis; Piomelli, Piomelli; Davison, Davison; Marnett, Marnett; Di Marzo, Di Marzo; Pittman, Pittman; Patel, Patel; Sharkey, Sharkey
  • Endocannabinoid‐mediated synaptic plasticity in the CNS
    Chevaleyre, Chevaleyre; Takahashi, Takahashi; Castillo, Castillo
  • Long‐lasting self‐inhibition of neocortical interneurons mediated by endocannabinoids
    Bacci, Bacci; Huguenard, Huguenard; Prince, Prince
  • Identification of a potent and highly efficacious, yet slowly desensitizing CB1 cannabinoid receptor agonist
    Luk, Luk; Jin, Jin; Zvonok, Zvonok; Lu, Lu; Lin, Lin; Chavkin, Chavkin; Makriyannis, Makriyannis; Mackie, Mackie
  • Cannabinoids, electrophysiology, and retrograde messengers: challenges for the next 5 years
    Straiker, Straiker; Mackie, Mackie
  • Functional selectivity and classical concepts of quantitative pharmacology
    Urban, Urban; Clarke, Clarke; Von Zastrow, Von Zastrow; Nichols, Nichols; Kobilka, Kobilka; Weinstein, Weinstein; Javitch, Javitch; Roth, Roth; Christopoulos, Christopoulos; Sexton, Sexton; Miller, Miller; Spedding, Spedding; Mailman, Mailman
  • Agonist selective modulation of tyrosine hydroxylase expression by cannabinoid ligands in a murine neuroblastoma cell line
    Bosier, Bosier; Tilleux, Tilleux; Najimi, Najimi; Lambert, Lambert; Hermans, Hermans
  • Agonist‐directed trafficking of response by endocannabinoids acting at CB2 receptors
    Shoemaker, Shoemaker; Ruckle, Ruckle; Mayeux, Mayeux; Prather, Prather
  • Cannabinoid agonist signal transduction in rat brain: comparison of cannabinoid agonists in receptor binding, G‐protein activation, and adenylyl cyclase inhibition
    Breivogel, Breivogel; Childers, Childers
  • Chemically distinct ligands promote differential CB1 cannabinoid receptor‐Gi protein interactions
    Mukhopadhyay, Mukhopadhyay; Howlett, Howlett
  • Activation of cannabinoid receptors in rat brain by WIN 55212‐2 produces coupling to multiple G protein alpha‐subunits with different potencies
    Prather, Prather; Martin, Martin; Breivogel, Breivogel; Childers, Childers
  • Functional selectivity through protean and biased agonism: who steers the ship?
    Kenakin, Kenakin
  • The CB1 cannabinoid receptor can sequester G‐proteins, making them unavailable to couple to other receptors
    Vasquez, Vasquez; Lewis, Lewis
  • Inverse, protean, and ligand‐selective agonism: matters of receptor conformation
    Kenakin, Kenakin
  • In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor?
    Yao, Yao; Mukherjee, Mukherjee; Fan, Fan; Garrison, Garrison; Daza, Daza; Grayson, Grayson; Hooker, Hooker; Dart, Dart; Sullivan, Sullivan; Meyer, Meyer
  • Inactivation of N‐acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids
    Leung, Leung; Saghatelian, Saghatelian; Simon, Simon; Cravatt, Cravatt
  • A biosynthetic pathway for anandamide
    Liu, Liu; Wang, Wang; Harvey‐White, Harvey‐White; Osei‐Hyiaman, Osei‐Hyiaman; Razdan, Razdan; Gong, Gong; Chan, Chan; Zhou, Zhou; Huang, Huang; Kim, Kim; Kunos, Kunos